Conmed (NYSE: CNMD) reported Q1 EPS of $0.70, $0.08 better than the analyst estimate of $0.62. Revenue for the quarter came in at $242.3 million versus the consensus estimate of $235.77 million.

GUIDANCE:

Conmed sees FY2022 revenue of $1.105-1.15 billion, versus the consensus of $1.09 billion.

For earnings history and earnings-related data on Conmed (CNMD) click here.